Razoxane (Standard)
Razoxane (Standard) is the analytical standard of Razoxane. This product is intended for research and analytical applications. Razoxane (ICRF 159) is an antiangiogenic topoisomerase II inhibitor, can be used for the research of renal cell carcinoma (RCC) [1].
Product Specifications
CAS Number
21416-67-1
UNSPSC
12352100
Target
Reference Standards; Topoisomerase
Related Pathways
Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
CC(CN(CC(N1)=O)CC1=O)N(CC(N2)=O)CC2=O
Molecular Formula
C11H16N4O4
Molecular Weight
268.27
References & Citations
[1]J P Braybrooke, et al. A phase II study of Razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Clin Cancer Res.2000; 6 (12) :4697-704.|[2]F Wingen, et al. Antimetastatic effects of Razoxane in a rat osteosarcoma model. Clin Exp Metastasis.Jan-Mar 1987; 5 (1) :9-16.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
13558124 3x 1.0µg DNA
BTK CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
MBS6336228-01 0.2 mL
PPFIBP1, ID (PPFIBP1, KIAA1230, Liprin-beta-1, Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, hSGT2) (FITC)
Sign In for Pricing
View Details MBS6336228-02 5x 0.2 mL
PPFIBP1, ID (PPFIBP1, KIAA1230, Liprin-beta-1, Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, hSGT2) (FITC)
Sign In for Pricing
View Details